Evaluation of the size of the kidney's parameters of patients with vesicoureteral reflux (VUR) can provide relevant knowledge about the prognosis factors of VUR's complications. The study aimed to assess the size of the renal parameters of children with VUR and compare the results with healthy matched cases by the ultrasound method. Methods: In this case-control study, children under 14 years of age with VUR in our pediatric urology practice from May 2019 to May 2020 were included. Eighty children were included in the two groups (case (40 cases) and control group (40 cases)) in the study. The case group included children with VUR, while the control group included healthy children. The data regarding Urinary Tract Infection (UTI), the length and width of the kidney, the size of the pelvis, parenchyma thickness, and volume of the kidney were recorded. Results: The mean age of children was 3.07 ± 3.05 years, and 35.0% of them were male. The mean number of UTIs in the VUR group was 1.90 ± 1.15 and in the control group was 1.10±0.30 (P=0.031). The incidence of UTIs was significantly higher in the VUR group than in the control group (P<0.001). Length, width, the posterior-anterior diameter of kidney, renal parenchyma thickness, and renal volume in the VUR group were significantly lower than the control group (P< 0.001). There was no difference between case and control groups in terms of anterior-posterior diameter of the pelvis (P= 0.653). Conclusions: The results showed that the size of kidneys parameters in children with VUR was less than in the control group. Also, the incidence of UTIs in the VUR group was significantly higher than in the control group. Ultrasound is a safe and non- invasive tool that can use for checking the size of the children's kidneys with VUR for predict of possible complications.
Background: Mental disorders, especially in children, can be manifested in different ways, which is of great importance to them, so the purpose of this evaluation was to evaluate the changes in psychiatric symptoms in children with ADHD. Method: This evaluation was performed as a descriptive-analytic study on 141 children with ADHD who were followed up for 6 months. At the beginning of the study and the third and sixth months after, patients' symptoms were assessed with the CBCL Behavior Checklist and the ADHD rating scale questionnaire, as well as the course of illness and association with other disorders. Finally, the data were entered into SPSS statistical software and analyzed. Results: The mean age of the children was 5.89±0.81 years and the prevalence of males was 68.8%. Among the two treatment groups, only the mean score below the ADHD-RS questionnaire score in the non-Ritalin group at the end of the third and sixth months was significantly lower than the Ritalin group. During the study in both treatment groups, the overall ADHD-RS questionnaire and both subscales of attention deficit hyperactivity disorder (ADHD) had a significant decrease from baseline to the end of the sixth month. In relation to the CBCL behavioral checklist, the mean score of the total checklist except for anxiety/depression in the non-Ritalin group and the somatic complaints subscale in the Ritalin group decreased significantly from baseline to the end of the sixth month. Conclusion: Based on the results observed in this evaluation, Ritalin had a significant effect on the symptoms of patients with ADHD, although these symptoms improved in both groups, however, further studies are needed.
